Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
Titel:
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
Auteur:
Ignatiadis, M. Litière, S. Rothe, F. Riethdorf, S. Proudhon, C. Fehm, T. Aalders, K. Forstbauer, H. Fasching, P.A. Brain, E. Vuylsteke, P. Guardiola, E. Lorenz, R. Pantel, K. Tryfonidis, K. Janni, W. Piccart, M. Sotiriou, C. Rack, B. Pierga, J.-Y.